Wysenski Nancy is a director of Cytokinetics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | CYTK Cytokinetics | Common Stock | Grant | Acquire A | No | No | 84.12 | 74 | 6.22 k | 17,156 |
2 Oct 23 | CYTK Cytokinetics | Common Stock | Grant | Acquire A | No | No | 27.88 | 224 | 6.25 k | 17,082 |
29 Jun 23 | ALKS Alkermes | RSU Ordinary Shares | Grant | Acquire A | No | No | 0 | 5,985 | 0.00 | 5,985 |
29 Jun 23 | ALKS Alkermes | Non Qualified Stock Option Ordinary Shares | Grant | Acquire A | No | No | 31.33 | 12,732 | 398.89 k | 12,732 |
10 May 23 | CYTK Cytokinetics | Common Stock | Grant | Acquire A | No | No | 0 | 5,000 | 0.00 | 16,671 |
10 May 23 | CYTK Cytokinetics | NQSO Common Stock | Grant | Acquire A | No | No | 37.89 | 10,000 | 378.90 k | 10,000 |
9 May 23 | ALKS Alkermes | Ordinary Shares | Sell | Dispose S | No | Yes | 31.2433 | 41,250 | 1.29 mm | 15,829 |
9 May 23 | ALKS Alkermes | Ordinary Shares | Option exercise | Acquire M | No | Yes | 31.13 | 6,250 | 194.56 k | 57,079 |
9 May 23 | ALKS Alkermes | Ordinary Shares | Option exercise | Acquire M | No | Yes | 31.13 | 35,000 | 1.09 mm | 50,829 |
9 May 23 | ALKS Alkermes | Non Qualified Stock Option Ordinary Shares | Option exercise | Dispose M | No | Yes | 31.13 | 6,250 | 194.56 k | 0 |